HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefan Roepke Selected Research

neodymium pyrocatechin disulfonate (NPD)

1/2021Reduced frontal cortical tracking of conflict between self-beneficial versus prosocial motives in Narcissistic Personality Disorder.
7/2014Stability of narcissistic personality disorder: tracking categorical and dimensional rating systems over a two-year period.
5/2014Narcissistic personality disorder: an integrative review of recent empirical data and current definitions.
2/2014Shame in patients with narcissistic personality disorder.
10/2013Gray matter abnormalities in patients with narcissistic personality disorder.
3/2013When grandiosity and vulnerability collide: Implicit and explicit self-esteem in patients with narcissistic personality disorder.
1/2013The Narcissistic Personality Inventory: a useful tool for assessing pathological narcissism? Evidence from patients with Narcissistic Personality Disorder.
5/2011Lack of empathy in patients with narcissistic personality disorder.
1/2010[Comorbidity in patients with narcissistic personality disorder in comparison to patients with borderline personality disorder].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stefan Roepke Research Topics

Disease

23Borderline Personality Disorder (Personality Disorders, Borderline)
01/2022 - 04/2009
9Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2022 - 04/2009
9Narcissistic Personality Disorder
01/2021 - 01/2010
6Wounds and Injuries (Trauma)
01/2022 - 12/2016
6Mental Disorders (Mental Disorder)
01/2022 - 01/2010
3Autism Spectrum Disorder
02/2022 - 01/2019
3Major Depressive Disorder (Major Depressive Disorders)
01/2022 - 09/2013
2Obesity
12/2020 - 10/2010
2Personality Disorders (Personality Disorder)
07/2014 - 01/2013
1Genetic Risk Score
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
12/2020
1Cognition Disorders
01/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016
1Medically Unexplained Symptoms
09/2013
1Depressive Disorder (Melancholia)
09/2013
1Bipolar Disorder (Manic Depressive Psychosis)
09/2013
1Illusions (Auditory Illusions)
03/2013
1Mood Disorders (Mood Disorder)
01/2010
1Substance-Related Disorders (Drug Abuse)
01/2010
1Antisocial Personality Disorder (Antisocial Personality)
01/2010
1Hypersensitivity (Allergy)
03/2004

Drug/Important Bio-Agent (IBA)

10Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 04/2015
9neodymium pyrocatechin disulfonate (NPD)IBA
01/2021 - 01/2010
3Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
10/2016 - 07/2014
2Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2020
2Oxytocin (Pitocin)FDA LinkGeneric
01/2022 - 07/2019
2Testosterone (Sustanon)FDA Link
02/2021 - 01/2016
2Antidepressive Agents (Antidepressants)IBA
12/2020 - 09/2013
2Clonidine (ST 155)FDA LinkGeneric
12/2018 - 04/2009
1Oxytocin Receptors (Oxytocin Receptor)IBA
01/2022
1Biological ProductsIBA
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2020
1Simvastatin (Zocor)FDA LinkGeneric
12/2020
1EscitalopramFDA Link
12/2020
1AmylasesFDA Link
10/2019
1Steroid Receptors (Steroid Receptor)IBA
01/2019
1Pharmaceutical PreparationsIBA
12/2018
1Yohimbine (Yocon)IBA
12/2018
1Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1CannabinoidsIBA
01/2018
1EndocannabinoidsIBA
01/2018
1anandamide (arachidonylethanolamide)IBA
01/2018
1Prazosin (Minipress)FDA LinkGeneric
01/2017
1Doxazosin (Cardura)FDA LinkGeneric
01/2017
1SteroidsIBA
01/2016
1FludrocortisoneIBA
04/2015
1Dopa DecarboxylaseIBA
11/2014
1Quetiapine Fumarate (Seroquel)FDA Link
09/2013
1CitalopramFDA LinkGeneric
09/2013
1butyrimidylpyridine disulfide- insulinIBA
01/2013
11- (diethylaminopropyl)- 4- phenylpiperazineIBA
06/2012
1AndrogensIBA
10/2010
1Glucose (Dextrose)FDA LinkGeneric
10/2010
1Valproic Acid (Depakote)FDA LinkGeneric
03/2004

Therapy/Procedure

2Therapeutics
09/2013 - 03/2011
1Transcranial Direct Current Stimulation
01/2019
1Complementary Therapies (Alternative Medicine)
01/2019
1Ambulatory Care (Outpatient Care)
10/2014
1Drug Therapy (Chemotherapy)
04/2009